Hemodynamic Effects of Milrinone in Pediatric Patients after Cardiac Surgery

蔡及明,陈玲,史珍英,黄惠民,徐卓明,周燕萍

DOI: https://doi.org/10.3969/j.issn.0253-9934.2001.01.013

2001-01-01

Abstract:Objective To investigate the hemodynamic effects of short-term intravenous milrione in patients undergoing cardiac surgery. Methods 22 patients with pulmonary hypertension or potential low cardiac output were randomly devided into two groups:Group A( n = 15); Group B(n=7). In both groups Milrinone 50μg/kg was given in bolus, then 0.25, 0.5, 0.75μg·kg-1 ·min-1 in Group A while normal saline was given in Group B as maintanence dose. Variables as baseline dose, loading dose were administered over 15 minutes, 30, 60, 90 minutes after infusion and 90 minutes after cessation were measured. Results Compared with the baseline dose and after loading dose, milrinone markedly increased CI, SI and HR (+16.1%,+8.9%,+5.8%),decreased PVRI and SVRI (-21.9%,-21.49％ ), lowered mRAP, mPAP and TPG (-14.79％,-13.3%,-7.89％), but without alteration in RPI (P＞0.05). Compared with placebo treatment, milrinone 50 μg/kg followed by 0.5 ～ 0.75 μtg· kg- 1· min- 1 was effective in improving CI and 0. 75 μg/kg· min was more favorable in lowering PVRI, mPAP while hymodynamic changes fell to the levcl of the placebo group. During administration, the total effective rate was 90.9 %. The incidence of thrombocytopenia and arrhythmia in both were 9.1%. Conclusion Milrinone can improve cardiac output and decrease the vascular resistance particularly in relaxation of pulmonary artery without increasing the cardiac oxygen consumption, also, being effective and relatively safe.